Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia
- PMID: 28856582
- DOI: 10.1007/s10875-017-0437-z
Helicobacter bilis-Associated Suppurative Cholangitis in a Patient with X-Linked Agammaglobulinemia
Abstract
ᅟ: Helicobacter bilis is a commensal bacterium causing chronic hepatitis and colitis in mice. In humans, enterohepatic Helicobacter spp. are associated with chronic hepatobiliary diseases.
Purpose: We aimed at understanding the microbial etiology in a patient with X-linked agammaglobulinemia presenting with suppurative cholangitis.
Methods: 16S rDNA PCR directly performed on a liver biopsy retrieved DNA of H. bilis.
Results: Clinical outcome resulted in the normalization of clinical and biological parameters under antibiotic treatment by a combination of ceftriaxone, metronidazole, and doxycyclin followed by a 2-week treatment with moxifloxacin and a 2-month treatment with azithromycin.
Conclusion: In conclusion, these data suggest a specific clinical and microbiological approach in patients with humoral deficiency in order to detect H. bilis hepatobiliary diseases.
Keywords: Bruton’s disease; Helicobacter bilis; agammaglobulinemia; cholangitis.
Similar articles
-
Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature.Front Cell Infect Microbiol. 2022 Feb 4;11:807136. doi: 10.3389/fcimb.2021.807136. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35186782 Free PMC article. Review.
-
Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia.J Clin Immunol. 2012 Dec;32(6):1404-8. doi: 10.1007/s10875-012-9750-8. Epub 2012 Jul 28. J Clin Immunol. 2012. PMID: 22843217 Review.
-
Chronic skin lesions from a patient with Bruton's X-linked agammaglobulinemia.J Clin Microbiol. 2011 Feb;49(2):483, 770. doi: 10.1128/JCM.02020-10. J Clin Microbiol. 2011. PMID: 21297007 Free PMC article. No abstract available.
-
Helicobacter cinaedi bacteremia resulting from antimicrobial resistance acquired during treatment for X-linked agammaglobulinemia.J Infect Chemother. 2016 Oct;22(10):704-6. doi: 10.1016/j.jiac.2016.02.008. Epub 2016 Mar 31. J Infect Chemother. 2016. PMID: 27040158
-
Chronic hepatitis, hepatic dysplasia, fibrosis, and biliary hyperplasia in hamsters naturally infected with a novel Helicobacter classified in the H. bilis cluster.J Clin Microbiol. 2009 Nov;47(11):3673-81. doi: 10.1128/JCM.00879-09. Epub 2009 Sep 16. J Clin Microbiol. 2009. PMID: 19759229 Free PMC article.
Cited by
-
Use of Immunoglobulin Replacement Therapy in Clinical Practice: A Review.J Immunother Precis Oncol. 2025 Jan 10;8(1):34-46. doi: 10.36401/JIPO-24-7. eCollection 2025 Feb. J Immunother Precis Oncol. 2025. PMID: 39811426 Free PMC article. Review.
-
Research-Relevant Conditions and Pathology of Laboratory Mice, Rats, Gerbils, Guinea Pigs, Hamsters, Naked Mole Rats, and Rabbits.ILAR J. 2021 Dec 31;62(1-2):77-132. doi: 10.1093/ilar/ilab022. ILAR J. 2021. PMID: 34979559 Free PMC article. Review.
-
Helicobacter bilis Contributes to the Occurrence of Inflammatory Bowel Disease by Inducing Host Immune Disorders.Biomed Res Int. 2022 Aug 9;2022:1837850. doi: 10.1155/2022/1837850. eCollection 2022. Biomed Res Int. 2022. PMID: 35983246 Free PMC article. Review.
-
Humoral immunodeficiencies: conferred risk of infections and benefits of immunoglobulin replacement therapy.Transfusion. 2018 Dec;58 Suppl 3(Suppl 3):3056-3064. doi: 10.1111/trf.15020. Transfusion. 2018. PMID: 30536429 Free PMC article. Review.
-
Infections With Enterohepatic Non-H. pylori Helicobacter Species in X-Linked Agammaglobulinemia: Clinical Cases and Review of the Literature.Front Cell Infect Microbiol. 2022 Feb 4;11:807136. doi: 10.3389/fcimb.2021.807136. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35186782 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous